Kavar Capital Partners Group, LLC Abbott Laboratories Transaction History

Kavar Capital Partners Group, LLC

$630 Million
Q3 2024

A detailed history of Kavar Capital Partners Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 41,927 shares of ABT stock, worth $4.86 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

41,927

Previous 42,971 2.43%

Holding current value

$4.86 Million

Previous $4.47 Million 7.05%

% of portfolio

0.76%

Previous 0.81%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $104,473 - $123,327	-1,044 Reduced 2.43%	41,927 $4.78 Million
Q2 2024 Jul 19, 2024	SELL	$100.73 - $112.44 $243,665 - $271,992	-2,419 Reduced 5.33%	42,971 $4.47 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $5.08 Million - $5.61 Million	-46,420 Reduced 50.56%	45,390 $5.16 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $3.8 Million - $4.65 Million	42,106 Added 84.71%	91,810 $10.1 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $52,159 - $62,582	546 Added 1.11%	49,704 $4.81 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $28,218 - $31,441	280 Added 0.57%	49,158 $5.36 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $19,178 - $22,573	-198 Reduced 0.4%	48,878 $4.95 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $131,658 - $154,455	1,385 Added 2.9%	49,076 $5.39 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $42,090 - $48,733	435 Added 0.92%	47,691 $4.62 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $82,268 - $99,436	806 Added 1.74%	47,256 $5.13 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $246,511 - $300,604	2,162 Added 4.88%	46,450 $5.5 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $127,429 - $156,030	1,103 Added 2.55%	44,288 $6.23 Million
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $8,282 - $9,163	-71 Reduced 0.16%	43,185 $5.1 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $1.11 Million - $1.3 Million	10,459 Added 31.89%	43,256 $5.02 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $111,016 - $130,794	-1,020 Reduced 3.02%	32,797 $3.93 Million
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $3.55 Million - $3.87 Million	33,817 New	33,817 $3.7 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.

Account

Kavar Capital Partners Group, LLC Abbott Laboratories Transaction History